Dépôt numérique
RECHERCHER

Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activity

Téléchargements

Téléchargements par mois depuis la dernière année

Plus de statistiques...

Thamri, Amal; Létourneau, Myriam; Djboulian, Alex; Chatenet, David; Déziel, Éric ORCID logoORCID: https://orcid.org/0000-0002-4609-0115; Castonguay, Annie ORCID logoORCID: https://orcid.org/0000-0001-5705-6353 et Perreault, Jonathan (2017). Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activity PLoS One , vol. 12 , nº 3. : e0173783: 1-12. DOI: 10.1371/journal.pone.0173783.

[thumbnail of Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activity.pdf]
Prévisualisation
PDF - Version publiée
Disponible sous licence Creative Commons Attribution.

Télécharger (1MB) | Prévisualisation

Résumé

Cationic antimicrobial peptides (CAMPs) occur naturally in numerous organisms and are considered as a class of antibiotics with promising potential against multi-resistant bacteria. Herein, we report a strategy that can lead to the discovery of novel small CAMPs with greatly enhanced antimicrobial activity and retained antibiofilm potential. We geared our efforts towards i) the N-terminal cysteine functionalization of a previously reported small synthetic cationic peptide (peptide 1037, KRFRIRVRV-NH2), ii) its dimerization through a disulfide bond, and iii) a preliminary antimicrobial activity assessment of the newly prepared dimer against Pseudomonas aeruginosa and Burkholderia cenocepacia, pathogens responsible for the formation of biofilms in lungs of individuals with cystic fibrosis. This dimer is of high interest as it does not only show greatly enhanced bacterial growth inhibition properties compared to its pep1037 precursor (up to 60 times), but importantly, also displays antibiofilm potential at sub-MICs. Our results suggest that the reported dimer holds promise for its use in future adjunctive therapy, in combination with clinically-relevant antibiotics.

Type de document: Article
Mots-clés libres: -
Centre: Centre INRS-Institut Armand Frappier
Date de dépôt: 24 juin 2017 07:41
Dernière modification: 21 févr. 2022 19:56
URI: https://espace.inrs.ca/id/eprint/5305

Gestion Actions (Identification requise)

Modifier la notice Modifier la notice